Literature DB >> 11472695

Determinants and prognostic implications of terminal QRS complex distortion in patients treated with primary angioplasty for acute myocardial infarction.

C W Lee1, M K Hong, H S Yang, S W Choi, J J Kim, S W Park, S J Park.   

Abstract

Terminal QRS complex distortion on admission has an impact on a patient's prognosis after primary angioplasty for acute myocardial infarction (AMI). We evaluated the determinants and prognostic significance of terminal QRS complex distortion in 153 consecutive patients with AMI after primary angioplasty. The study population was divided into 2 groups according to the presence (group I, n = 41) or absence (group II, n = 112) of terminal QRS complex distortion. The primary end points were the occurrence, within 6 weeks after AMI, of death, nonfatal reinfarction, or congestive heart failure. Baseline characteristics were similar between the 2 groups. However, patients in group I had higher peak levels of serum creatine kinase than those in group II (5,100 +/- 3,100 vs 3,000 +/- 1,800 U/L, respectively, p <0.01). The rate of angiographic no-reflow (Thrombolysis In Myocardial Infarction flow grade < or =2) was 31.7% in group I and 10.7% in group II (p <0.01). The predischarge left ventricular ejection fraction was 45.0 +/- 12.0% in group I and 54.0 +/- 8.0% in group II (p <0.01). Multivariate analysis identified the pressure-derived fractional collateral flow index and the culprit lesion in the left anterior descending coronary artery as independent determinants of the terminal QRS complex distortion. No patients died during 6 weeks of follow-up. The 2 groups were similar for life-threatening arrhythmia or reinfarction. However, there were more patients in group I than in group II with congestive heart failure (26.8% vs 5.4%, respectively, p <0.01) or who reached the primary end points (29.3% vs 5.4%, respectively, p <0.01). In conclusion, terminal QRS complex distortion on admission is associated with poor clinical outcome after primary angioplasty for AMI, and collateral flow may have a major influence on terminal QRS complex distortion during AMI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472695     DOI: 10.1016/s0002-9149(01)01627-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis.

Authors:  Y Birnbaum; B J Drew
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

2.  The Predictive Value of Fragmented QRS and QRS Distortion for High-Risk Patients with STEMI and for the Reperfusion Success.

Authors:  Zulkif Tanriverdi; Huseyin Dursun; Mustafa Aytek Simsek; Baris Unal; Omer Kozan; Dayimi Kaya
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-02       Impact factor: 1.468

3.  QRS complex distortion (Grade 3 ischaemia) as a predictor of myocardial damage assessed by cardiac magnetic resonance imaging and clinical prognosis in patients with ST-elevation myocardial infarction.

Authors:  Karl-Philipp Rommel; Hadeel Badarnih; Steffen Desch; Matthias Gutberlet; Gerhard Schuler; Holger Thiele; Ingo Eitel
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-06-09       Impact factor: 6.875

4.  Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.

Authors:  M Sejersten; Y Birnbaum; R S Ripa; C Maynard; G S Wagner; P Clemmensen
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

5.  Comparison of different methods of ST segment resolution analysis for prediction of 1-year mortality after primary angioplasty for acute myocardial infarction.

Authors:  Jakub Przyluski; Maciej Karcz; Lukasz Kalińczuk; Mariusz Kruk; Jerzy Pregowski; Edyta Kaczmarska; Joanna Petryka; Paweł Bekta; Tomasz Deptuch; Cezary Kepka; Adam Witkowski; Witold Ruzyllo
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

6.  The impact of preinfarction angina on electrocardiographic ischemia grades in patients with acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Turgay Celik; U Cagdas Yuksel; Atila Iyisoy; Selim Kilic; Ejder Kardesoglu; Baris Bugan; Ersoy Isik
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

7.  Myocardial salvage for ST-elevation myocardial infarction with terminal QRS distortion and restoration of brisk epicardial coronary flow.

Authors:  Nobuo Nakamura; Masahiro Gohda; Osamu Satani; Yoshiaki Tomobuchi; Yuji Ueno; Takashi Tanimoto; Hironori Kitabata; Shigeho Takarada; Takashi Kubo; Masato Mizukoshi; Kumiko Hirata; Atsushi Tanaka; Toshio Imanishi; Takashi Akasaka
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

8.  Terminal QRS Distortion in ST Elevation Myocardial Infarction as a Prediction of Mortality: Systematic Review and Meta-Analysis.

Authors:  Narut Prasitlumkum; Natee Sirinvaravong; Nath Limpruttidham; Pattara Rattanawong; Elysse Tom; Chanavuth Kanitsoraphan; Pakawat Chongsathidkiet; Thosaporn Boondarikpornpant
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

9.  The relationship between grade of ischemia, success of reperfusion, and type of thrombolytic regimen.

Authors:  Burak Ayça; Cenk Conkbayır; Fahrettin Katkat; Kamil Gulsen; Fatih Akin; Ertuğrul Okuyan; Murat Baskurt; Barıs Okcun
Journal:  Med Sci Monit       Date:  2015-03-08

10.  Terminal QRS complex distortion on the admission electrocardiogram in anterior acute myocardial infarction and association with residual flow and infarct size after primary angioplasty.

Authors:  Hyun Suk Yang; Cheol Whan Lee; Myeong-Ki Hong; Dae-Hyuk Moon; Young-Hak Kim; Sang-Gon Lee; Ki-Hoon Han; Jae-Joong Kim; Seong-Wook Park; Seung-Jung Park
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.